Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
Moderna’s mRNA flu vaccine shows phase 3 success, plans for combo shots by 2025
Moderna has achieved significant progress in its quest to develop an mRNA flu vaccine, with the updated mRNA-1010 version successfully ...
Eiger halts hepatitis drug development after liver toxicity, seeks funding for other programs
Eiger BioPharmaceuticals has made the decision to discontinue the pursuit of a home for peginterferon lambda, a drug that was ...
BioMarin R&D chief reveals two new pipeline candidates and strategy to sustain innovation
BioMarin, the California-based biotech giant, is embarking on a mission to create its most robust pipeline in history, with a ...
Zeta Surgical gets FDA clearance for its neurosurgery navigation system
Zeta Surgical is revolutionizing surgical precision with its newly FDA-cleared digital navigation system, designed to guide surgeons through complex brain ...
Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments
Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...
Phesi partners with Krystelis to boost diversity in clinical trials
Clinical research and analytics specialist Phesi, in collaboration with Krystelis, has introduced a groundbreaking service aimed at enhancing the diversity ...
U.S. government hires Icon to run trial of new COVID-19 vaccines
Icon, a prominent Contract Research Organization (CRO), has been chosen by the US Department of Health and Human Services’ Biomedical ...
Madrigal’s NASH drug gets fast-track review from FDA, no panel needed
In the wake of a recent CEO transition, Madrigal Pharmaceuticals has disclosed that its nonalcoholic steatohepatitis (NASH) drug has been ...
FDA cracks down on 8 firms selling illegal eye drugs online
In a recent development, eight companies have come under scrutiny for allegedly producing unauthorized eye medications, according to the FDA’s ...
Sanofi teams up with Ice-T to scare people into getting flu shots
Sanofi is breaking the mold with a bold and captivating campaign aimed at alerting older adults to the perils of ...
Orchid Pharma to produce GSK and Shionogi’s antibiotic for global access
Orchid Pharma, a subsidiary of India’s Dhanuka Labs, has secured a sublicense to manufacture the antibiotic cefiderocol. This development is ...
FDA warns Ohio company for serious violations in drug repackaging process
Ohio-based pharmaceutical repackaging company, Safecor Health, finds itself in the FDA’s crosshairs as it receives a stern warning letter highlighting ...
HHS says Merck can’t sue over Medicare drug price talks
Merck & Co., a prominent pharmaceutical company, led the charge in challenging the contentious Medicare price negotiation provisions outlined in ...
Moderna to cut down COVID booster production amid low demand: Reuters reports
While the FDA and the Centers for Disease Control and Prevention (CDC) have given their green light to updated COVID ...
Ferring launches bladder cancer gene therapy Adstiladrin in US through early experience program
Ferring Pharmaceuticals achieved a significant milestone by administering its groundbreaking gene therapy, Adstiladrin, to its first commercial patient. This innovative ...
FDA panel votes against phenylephrine, a common decongestant drug in many cold medicines
For decades, the shelves of American pharmacies have been stocked with hundreds of oral decongestant products containing phenylephrine, promising relief ...
CureVac selects mRNA flu vaccine candidate for GSK collaboration, but data remains secret
CureVac, the renowned biotech company, has made a significant stride in its quest to develop an mRNA influenza vaccine. While ...
Neurocrine advances potential blockbuster drug for endometrial hyperplasia after phase 3 success
Neurocrine Biosciences is banking on its hyperplasia drug, crinecerfont, which analysts predict could be a blockbuster. The company has been ...
Exelixis partners with AI company Insilico to discover new drugs, LIB sells China rights for PCSK9 drug
Exelixis, the pharmaceutical company recognized for its solid tumor medication Cabometyx, is adopting artificial intelligence (AI) to bolster its pipeline. ...
CDC launches ‘Wild to Mild’ campaign to boost flu vaccination rates among high-risk groups
The CDC is embarking on an ambitious mission to reframe perceptions of flu vaccines as a response to declining vaccination ...
AbbVie’s Skyrizi beats J&J’s Stelara in Crohn’s disease showdown
AbbVie’s revolutionary anti-inflammatory medication, Skyrizi, has been consistently outperforming its competitors in recent clinical trials, making waves in the field ...
Bristol Myers Squibb celebrates 10 years of cycling for cancer with a cross-country ride and a $1.5M donation
Bristol Myers Squibb is commemorating a decade of charitable efforts by organizing a 3,000-mile bike ride to support cancer patients. ...
OVID Health launches podcast to improve patient-pharma communication
OVID Health, a healthcare communications agency, is embarking on a fresh initiative with the launch of a podcast called “OVIDcast: ...
Xspray Pharma settles with BMS over Sprycel generic, awaits FDA nod
Xspray Pharma, which encountered an FDA setback in July, was initially aiming to launch its competitor to Bristol Myers Squibb’s ...
Novartis recalls lot of Sandimmune due to crystal formation in oral solution
Novartis is taking action to recall one lot of its immunosuppressant medication, Sandimmune, due to an unexpected issue with crystallization ...
2seventy Bio slashes 176 jobs and looks for new CEO after cell therapy setback
2seventy bio, the spinoff from bluebird bio, is undergoing significant changes under the leadership of CEO Nick Leschly. The company ...
Vertex partners with Septerna to develop GPCR-targeting drugs for rare diseases
Septerna, a biotech company, has secured an additional $47.5 million in funding through a licensing agreement with Vertex, a prominent ...
Arbutus scraps COVID-19 and RNA degradation programs after disappointing preclinical results
Arbutus Biopharma has made significant strategic shifts by discontinuing its involvement in COVID-19 research and RNA destabilizer programs, redirecting its ...
Acelyrin’s lead drug flops in phase 3 trial, wiping out half of its market value
Acelyrin, a biotech company based in Los Angeles, has delivered a shocking blow to its investors. Despite successfully raising an ...
FDA approves Aphexda for stem cell mobilization in multiple myeloma
After a decade of limited progress, the FDA has granted approval for the use of BioLineRx’s motixafortide, also known as ...
